QUALITY OF LIFE IN METASTATIC PROSTATE CANCER AMONG MEN OF LOWER SOCIOECONOMIC STATUS: FEASIBILITY AND CRITERION RELATED VALIDITY OF 3 MEASURES
The Journal of UrologyPublished 1 November 1998
Sara J. Knight, Joan S. Chmiel, Timothy M. Kuzel, Lisa K. Sharp, MARY ALBERS, Robert Fine
Citations35
SJR quartileQ1
SJR score2.21
SNIP2.70
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Each quality of life instrument required less than 10 minutes of interviewer administration and was able to discriminate between patients with stable versus progressive disease on several health status domains, supporting the feasibility and validity ofquality of life measurement in patients of low socioeconomic status with metastatic cancer.
Abstract
These data support the feasibility and validity of quality of life measurement in patients of low socioeconomic status with metastatic prostate cancer. Consideration should be given to adding quality of life instruments to patient encounter even among low socioeconomic status, low literacy populations.
Keywords
MedicineEconomics, Econometrics and Finance
PubMedThe MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
33,975 Citations1992John E. Ware, Cathy D. Sherbourne
A 36-item short-form survey designed for use in clinical practice and research, health policy evaluations, and general population surveys to survey health status in the Medical Outcomes Study is constructed.
Medical CareThe MOS 36-ltem Short-Form Health Survey (SF-36)
29,791 Citations1992John E. Ware, Cathy D. Sherbourne
A 36-item short-form survey to survey health status in the Medical Outcomes Study and designed for use in clinical practice and research, health policy evaluations, and general population surveys.
JNCI Journal of the National Cancer InstituteThe European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
15,964 Citations1993N.K. Aaronson, Sam H. Ahmedzai +17 more
The reliability and validity of the EORTC QLQ-C30 questionnaire were highly consistent across the three language-cultural groups studied: patients from English-speaking countries, Northern Europe, and Southern Europe.
Journal of Clinical OncologyThe Functional Assessment of Cancer Therapy scale: development and validation of the general measure.
6,031 Citations1993David Cella, David S. Tulsky +8 more
The FACT-G meets or exceeds all requirements for use in oncology clinical trials, including ease of administration, brevity, reliability, validity, and responsiveness to clinical change.
CA A Cancer Journal for CliniciansCancer statistics, 1998
2,384 Citations1998Sarah Landis, Thomas S. Murray +2 more
The Surveillance Research Program of the American Cancer Society's Department of Epidemiology and Surveillance reports its 32nd annual compilation of cancer incidence, mortality, and survival data for the United States and around the world.
CancerThe use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinoma
2,246 Citations1948David A. Karnofsky, Walter H. Abelmann +2 more
Journal of Clinical OncologyChemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
1,576 Citations1996I. F. Tannock, David Osoba +9 more
Chemotherapy with mitoxantrone and prednisone provides palliation for some patients with symptomatic hormone-resistant prostate cancer and most responding patients had an improvement in quality-of-life scales and a decrease in serum prostate-specific antigen (PSA) level.
Journal of Chronic DiseasesMeasuring the quality of life of cancer patients
1,536 Citations1981Walter O. Spitzer, Annette J. Dobson +6 more
The aim has been to provide a new measure that can help physicians assess the relative benefits and risks of various treatments for serious illness and of supportive programs such as palliative care or hospice service.
Journal of Clinical OncologyMeasuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.
1,050 Citations1984Harvey Schipper, Jennifer Clinch +2 more
The Functional Living Index-Cancer is proposed as an adjunct to clinical trials assessment and may provide additional patient functional information on which to analyse the outcome of clinical trials or offer specific advice to individual patients.
JAMAQuality-of-Life Outcomes in Men Treated for Localized Prostate Cancer
1,027 Citations1995Mark S. Litwin, Ron D. Hays +5 more
It is concluded that in addition to general HRQOL, disease-targeted measures must be used to assess outcomes of care in men treated for localized prostate cancer.
UrologyMeasuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-prostate instrument
682 Citations1997Peg Esper, Fei Mo +4 more
Sensitivity to change in performance status and PSA score over a 2-month period suggested that some subscales of the FACT-Prostate (P) (including the PCS) are sensitive to meaningful clinical change.
Journal of Clinical OncologyRelation between literacy, race, and stage of presentation among low-income patients with prostate cancer.
377 Citations1998Charles L. Bennett, M. Rosario Ferreira +6 more
Low literacy may be an overlooked but significant barrier to the diagnosis of early-stage prostate cancer among low-income white and black men and the development of culturally sensitive, low-literacy educational materials may improve patient awareness of prostate cancer and improve the frequency of diagnosis ofEarly-stage cancer.
CancerQuality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care
326 Citations1994Alice B. Kornblith, Harry W. Herr +3 more
A data base was established to examine the nature and extent of problems in patients' and spouses' adaptation and their interrelationships and the effect of disease stage combined with treatment regimen on patients' quality of life.
Quality of Life ResearchThe CARES: a generic measure of health-related quality of life for patients with cancer
246 Citations1992Patricia A. Ganz, C. A. C. Schag +2 more
This paper represents the first discussion of the performance of theCARES across separate cancer sites and phases of the disease, and demonstrated that the CARES is responsive to changes in health-related quality of life over time.
Journal of Clinical OncologyUse of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer.
165 Citations1994Malcolm J. Moore, David Osoba +8 more
Mitoxantrone with low-dose prednisone is a well-tolerated treatment regimen that has some beneficial effects on disease-related symptoms and quality of life for patients with advanced prostate cancer.
UrologyHealth-related quality of life among patients with metastatic prostate cancer
148 Citations1997Peter C. Albertsen, Neil K. Aaronson +3 more
Patients in remission receiving treatment with a luteinizing hormone-releasing hormone agonist and flutamide have a quality of life that is indistinguishable from a matched male population without prostate cancer and aquality of life significantly better than that of men with androgen-resistant disease.
Quality of Life ResearchQuality of life and psychosocial status in stage D prostate cancer
137 Citations1992Barrie R. Cassileth, Mark S. Soloway +6 more
This investigation, which is among the first to evaluate patients' appraisals of their lives following treatment choices for advanced prostatic cancer, argues compellingly for including quality of life in assessments of therapy.
European Journal of Cancer and Clinical OncologyQuality of life and treatment of hormone resistant metastatic prostatic cancer
137 Citations1990Sophie D. Fosså, Neil K. Aaronson +5 more
72 patients with hormone resistant, progressing prostatic cancer completed a self-administered questionnaire to assess subjective morbidity and quality of life before they were entered into a phase III trial of estramustine vs. mitomycin.
CancerA comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy
134 Citations1993Harry W. Herr, Alice B. Kornblith +1 more
The quality of life in patients who elected to receive hormonal therapy for newly diagnosed asymptomatic metastatic prostate cancer was compared with a comparable group of patients who chose to defer immediate intervention.
UrologyComparison of perspectives on prostate cancer: analyses of survey data
123 Citations1997E. David Crawford, Charles L. Bennett +6 more
Three issues were addressed among patients who belong to a prostate cancer support group as well as among a second group of urologists who treat prostate cancer: goals for prostate cancer treatment, information given and recalled about the disease and therapy, and extent to which educational and emotional needs are being met.
Urologic Clinics of North AmericaAdvanced Prostatic Carcinoma
120 Citations1991James M. Kozlowski, William J. Ellis +1 more
The risk-benefit analysis presented in this review is strongly supportive of early hormonal therapy and the development of novel treatment strategies effective against androgen-resistant tumor cells and their use in concert with early androgen deprivation.
CancerThe national cancer data base report on prostate cancer
75 Citations1995Tim E. Aldrich, Wendy Demark‐Wahnefried +5 more
This information provides national points of reference against which individual hospital performance can be compared and should be particularly helpful to cancer committees, tumor boards, and cancer registrars for the monitoring and evaluation of prostate cancer management in hospital cancer programs.
Environmental Health PerspectivesDifferences in cancer incidence, mortality, and survival between African Americans and whites.
73 Citations1995Brett L. Walker, L W Figgs +1 more
Evidence of different cancer patterns among African Americans and whites and potential risk factors associated with these cancers suggest that efforts aimed at changing lifestyles, achieving socioeconomic parity, and insuring environmental equity are likely to relieve African Americans of much of their disproportionate cancer burden.
CancerThe national cancer data base report on prostate cancer
33 Citations1994Curtis Mettlin, Gerald P. Murphy
The most current National Cancer Data Base data for prostate cancer are reviewed in this report and time trends in disease stage, treatment patterns, and survival are examined.
European UrologyQuality of Life of Patients withAdvanced and MetastaticProstatic Carcinoma
27 Citations1993H. Villavicencio
The quality of life of patients with advanced prostate cancer may be profoundly affected by local infiltration into adjacent organs and the occurrence of distant metastases and suitable palliative treatment for each secondary manifestation is recommended.
Medical CareThe Department of Veterans Affairs Medical Care System and the People It Serves
24 Citations1996Maria Liana Gesteira Fonseca, Mary E. Smith +2 more
Since the time that this manuscript was researched and written, major changes in both organizational structure and organizational culture have taken place in VHA.
CancerExpanding the definition of quality of life for prostate cancer
20 Citations1993John W. Sharp
This work focuses on the impact of the disease and its treatment on family caregivers, the possibility of age bias and ethical dilemmas in treatment decisions, and the specific concerns of black men in whom the disease is more common.
UrologyTreatment considerations for persons with metastatic prostate cancer: Survival versus out-of-pocket costs
20 Citations1997David B. Matchar, Douglas C McCrory +1 more
Physicians-varied in their perceptions of quality of life for persons with metastatic prostate cancer and in their willingness to prescribe flutamide and these perceptions and prescribing preferences are strongly influenced by factors other than health status or specific health benefits.
UrologyPerformance measurement in prostate cancer care: Beyond report cards
19 Citations1996Matthew Ullman, Charles Metzger +2 more
The complementary approach of combining "instrument panels" and clinical guidelines within an overall continuous quality improvement framework appears to have resulted in improved clinical outcomes and reduced costs in a six-physician urology group located in a heavily managed-care penetrated market.
Environmental Health PerspectivesDifferences in Cancer Incidence, Mortality, and Survival between African Americans and Whites
13 Citations1995Bailus Walker, Larry W. Figgs +1 more